Trastuzumab Completed Phase 1 Trials for Malignancies / Advanced Solid Tumors / Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01235897MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
NCT00005842Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer